Tag: Sivantos

All

Latest

WS Audiology Group CFO Søren Westh Lonning Resigns

WS Audiology announced that its Group CFO Søren Westh Lonning will step down on November 8, 2021, to fully focus on recovering from back pain issues. Michael Tyroller will assume the position as interim Group CFO from the same date after previously having acted as interim Group CFO of WS Audiology from June 1 until October 31, 2020.

All

Latest

Sivantos & Widex Finalize Merger to Become WS Audiology

EQT funds, owners of Sivantos, and the Tøpholm and Westermann families, owners of Widex, have announced the successful completion of the business combination between Sivantos and Widex. The newly created company will operate under the name WS Audiology and be headquartered in Lynge, Denmark, and Singapore.

63rd International EUHA Congress to Take Place October 17-19, 2018 in Hannover

The main topic of the 2018 EUHA Congress is “digitalization,” and all presentations will be available in both German and English. In addition to the lecture program, more than 130 exhibitors will be showcasing their latest technologies and innovative products in the fields of diagnostics, accessories, and design at the accompanying trade exhibition.

Read More

Survival Strategies in a Competitive Hearing Healthcare Market

To formulate any reasonable strategy for thriving in today’s hearing healthcare market, it is useful to understand where we are today, how we got here, and what might come in the future. Part 1 of this 2-part article offers a perspective about how industry consolidation has changed the hearing healthcare market and the current major trends that could influence the future strategies of an independent practice owner.

Read More

Sivantos and Widex Announce Plans to Merge

Sivantos and Widex have agreed to terms for merging the two companies. The combined company—pending what will probably be a long and possibly uncertain regulatory approval process—would position it on par with current global market leaders Sonova and William Demant Holding, with a worldwide market share of around 24-25% and revenues of approximately $1.9 billion.

Read More

Clinical Study Shows Significant Benefit of Own Voice Processing

This clinical trial suggests that Signia OVP provides a substantial improvement in own-voice satisfaction, and that this improvement is present for different fitting strategies, and for different ear-canal couplings. Moreover, when the satisfaction with OVP is compared to alternative solutions from competitive products, a significant OVP advantage was seen—to the extent that own-voice satisfaction with OVP using a closed fitting is equal or superior to other products using an open fitting.

Read More
Loading